We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$254M
AUM Growth
–
Cap. Flow
+$74.4M
Cap. Flow %
29.33%
Top 10 Hldgs %
85.82%
Holding
21
New
11
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$17.2M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.4M
3
ASRT
Assertio
ASRT
+$10.3M
4
ACHV icon
Achieve Life Sciences
ACHV
+$9.48M
5
NKTR icon
Nektar Therapeutics
NKTR
+$9.32M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLXP
1
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$19.8M 7.82%
+300,000
New +$17.2M
NKTR icon
2
Nektar Therapeutics
NKTR
$2.39B
$10.5M 4.15%
+60,737
New +$9.32M
ASRT
3
DELISTED
Assertio
ASRT
$10.4M 4.08%
+30,705
New +$10.3M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$10.2M 4%
+182,300
New +$11.4M
ACHV icon
5
Achieve Life Sciences
ACHV
$626M
$9.14M 3.6%
+424
New +$9.48M
MNKD icon
6
MannKind Corp
MNKD
$1.28B
$7.71M 3.04%
+236,957
New +$6.35M
ECYT
7
DELISTED
Endocyte, Inc. Common Stock
ECYT
$6.12M 2.41%
+465,763
New +$6.28M
NAVB
8
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$2.32M 0.91%
+43,404
New +$2.17M
RMTI icon
9
Rockwell Medical
RMTI
$26.2M
$1.62M 0.64%
+4,074
New +$1.73M
DNDN
10
DELISTED
DENDREON CORPORATION
DNDN
$328K 0.13%
+79,600
New +$339K
BGMS
11
Bio Green Med Solution Inc
BGMS
$5.05M
– –
0
– –
AMBI
12
DELISTED
Ambit Biosciences Corp
AMBI
$0 ﹤0.01%
+46
New +$329

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Tang Capital Management, which disclosed 21 positions worth $254M. Its ten largest holdings account for 86% of the portfolio.

Its largest position is SALIX PHARMACEUTICALS LTD DEL: 300,000 shares worth $19.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets.

  • Tang Capital Management's largest Q2 2013 buy was SALIX PHARMACEUTICALS LTD DEL: 300,000 shares worth $19.8M.
  • Tang Capital Management's ten largest holdings make up 86% of its $254M portfolio in Q2 2013.
  • Tang Capital Management disclosed 21 positions in Q2 2013, its first 13F filing on record.

Based on Tang Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.